CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 151 filers reported holding CHEMOCENTRYX INC in Q3 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $9,954,000 | -9.1% | 192,680 | -56.4% | 0.29% | -15.7% |
| Q2 2022 | $10,945,000 | -73.6% | 441,680 | -73.3% | 0.34% | -58.7% |
| Q1 2022 | $41,493,000 | -59.7% | 1,655,079 | -41.5% | 0.83% | +4.5% |
| Q4 2021 | $103,072,000 | +309.2% | 2,830,892 | +92.2% | 0.80% | +117.2% |
| Q3 2021 | $25,191,000 | +4169.7% | 1,473,200 | +14269.9% | 0.37% | +3560.0% |
| Q2 2020 | $590,000 | +45.3% | 10,252 | 0.0% | 0.01% | -9.1% |
| Q1 2020 | $406,000 | – | 10,252 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
| Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
| HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
| Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
| Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
| Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
| Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
| Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
| Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |